We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Updated: 4/24/2017
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease
Updated: 5/1/2017
Adalimumab to Mitigate Cardiovascular Risk in RA Patients With Well-Controlled Joint Disease
Status: Enrolling
Updated: 5/1/2017
Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease
Updated: 5/1/2017
Adalimumab to Mitigate Cardiovascular Risk in RA Patients With Well-Controlled Joint Disease
Status: Enrolling
Updated: 5/1/2017
Click here to add this to my saved trials
Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence
Updated: 5/1/2017
Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence
Status: Enrolling
Updated: 5/1/2017
Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence
Updated: 5/1/2017
Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence
Status: Enrolling
Updated: 5/1/2017
Click here to add this to my saved trials
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
Updated: 5/2/2017
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
Status: Enrolling
Updated: 5/2/2017
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
Updated: 5/2/2017
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
Status: Enrolling
Updated: 5/2/2017
Click here to add this to my saved trials
Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts
Updated: 5/4/2017
Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts
Status: Enrolling
Updated: 5/4/2017
Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts
Updated: 5/4/2017
Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts
Status: Enrolling
Updated: 5/4/2017
Click here to add this to my saved trials
Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens
Updated: 5/4/2017
Clinical and Laboratory Evaluation of Acute Rejection, Myocyte Growth, Repair, and Oxidative Stress Following de Novo Cardiac Transplant: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens With MPA TDM
Status: Enrolling
Updated: 5/4/2017
Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens
Updated: 5/4/2017
Clinical and Laboratory Evaluation of Acute Rejection, Myocyte Growth, Repair, and Oxidative Stress Following de Novo Cardiac Transplant: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens With MPA TDM
Status: Enrolling
Updated: 5/4/2017
Click here to add this to my saved trials
Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens
Updated: 5/4/2017
Clinical and Laboratory Evaluation of Acute Rejection, Myocyte Growth, Repair, and Oxidative Stress Following de Novo Cardiac Transplant: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens With MPA TDM
Status: Enrolling
Updated: 5/4/2017
Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens
Updated: 5/4/2017
Clinical and Laboratory Evaluation of Acute Rejection, Myocyte Growth, Repair, and Oxidative Stress Following de Novo Cardiac Transplant: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens With MPA TDM
Status: Enrolling
Updated: 5/4/2017
Click here to add this to my saved trials
IMPACT: Inactivity Monitoring and Physical Activity Controlled Trial
Updated: 5/10/2017
IMPACT: Inactivity Monitoring and Physical Activity Controlled Trial
Status: Enrolling
Updated: 5/10/2017
IMPACT: Inactivity Monitoring and Physical Activity Controlled Trial
Updated: 5/10/2017
IMPACT: Inactivity Monitoring and Physical Activity Controlled Trial
Status: Enrolling
Updated: 5/10/2017
Click here to add this to my saved trials
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites
Updated: 5/11/2017
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites: A Population-Based Study in Cincinnati, Ohio
Status: Enrolling
Updated: 5/11/2017
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites
Updated: 5/11/2017
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites: A Population-Based Study in Cincinnati, Ohio
Status: Enrolling
Updated: 5/11/2017
Click here to add this to my saved trials
Patients' Perspectives of Factors That Support the Management of Peripheral Arterial Disease for Improved Outcomes
Updated: 5/22/2017
A Study of Patients' Perspectives of Factors That Support the Management of Cardiac Care for Improved Outcomes in a Peripheral Arterial Disease Population
Status: Enrolling
Updated: 5/22/2017
Patients' Perspectives of Factors That Support the Management of Peripheral Arterial Disease for Improved Outcomes
Updated: 5/22/2017
A Study of Patients' Perspectives of Factors That Support the Management of Cardiac Care for Improved Outcomes in a Peripheral Arterial Disease Population
Status: Enrolling
Updated: 5/22/2017
Click here to add this to my saved trials
Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy
Updated: 5/23/2017
A Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy for the Treatment of Coronary Artery Disease Using Direct Intramyocardial Administration of an Adenovirus Vector Expressing the VEGF121 cDNA
Status: Enrolling
Updated: 5/23/2017
Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy
Updated: 5/23/2017
A Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy for the Treatment of Coronary Artery Disease Using Direct Intramyocardial Administration of an Adenovirus Vector Expressing the VEGF121 cDNA
Status: Enrolling
Updated: 5/23/2017
Click here to add this to my saved trials
Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy
Updated: 5/23/2017
A Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy for the Treatment of Coronary Artery Disease Using Direct Intramyocardial Administration of an Adenovirus Vector Expressing the VEGF121 cDNA
Status: Enrolling
Updated: 5/23/2017
Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy
Updated: 5/23/2017
A Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy for the Treatment of Coronary Artery Disease Using Direct Intramyocardial Administration of an Adenovirus Vector Expressing the VEGF121 cDNA
Status: Enrolling
Updated: 5/23/2017
Click here to add this to my saved trials
Study of Cardiovascular Disease and Obstructive Sleep Apnea
Updated: 6/1/2017
Pharmacologic Interventions for Cardiovascular Disease in Obstructive Sleep Apnea
Status: Enrolling
Updated: 6/1/2017
Study of Cardiovascular Disease and Obstructive Sleep Apnea
Updated: 6/1/2017
Pharmacologic Interventions for Cardiovascular Disease in Obstructive Sleep Apnea
Status: Enrolling
Updated: 6/1/2017
Click here to add this to my saved trials
Study of Cardiovascular Disease and Obstructive Sleep Apnea
Updated: 6/1/2017
Pharmacologic Interventions for Cardiovascular Disease in Obstructive Sleep Apnea
Status: Enrolling
Updated: 6/1/2017
Study of Cardiovascular Disease and Obstructive Sleep Apnea
Updated: 6/1/2017
Pharmacologic Interventions for Cardiovascular Disease in Obstructive Sleep Apnea
Status: Enrolling
Updated: 6/1/2017
Click here to add this to my saved trials
Study of Cardiovascular Disease and Obstructive Sleep Apnea
Updated: 6/1/2017
Pharmacologic Interventions for Cardiovascular Disease in Obstructive Sleep Apnea
Status: Enrolling
Updated: 6/1/2017
Study of Cardiovascular Disease and Obstructive Sleep Apnea
Updated: 6/1/2017
Pharmacologic Interventions for Cardiovascular Disease in Obstructive Sleep Apnea
Status: Enrolling
Updated: 6/1/2017
Click here to add this to my saved trials
Study of Cardiovascular Disease and Obstructive Sleep Apnea
Updated: 6/1/2017
Pharmacologic Interventions for Cardiovascular Disease in Obstructive Sleep Apnea
Status: Enrolling
Updated: 6/1/2017
Study of Cardiovascular Disease and Obstructive Sleep Apnea
Updated: 6/1/2017
Pharmacologic Interventions for Cardiovascular Disease in Obstructive Sleep Apnea
Status: Enrolling
Updated: 6/1/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Investigating Superion™ In Spinal Stenosis
Updated: 6/6/2017
A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis
Status: Enrolling
Updated: 6/6/2017
Click here to add this to my saved trials